Cambridge Investment Research Advisors
LONA

Cambridge Investment Research Advisors’s LeonaBio Inc LONA Stock Holding History

Cambridge Investment Research Advisors’s Portfolio LONA Stock Details LONA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,178
Closed -$32K – 3320
2024
Q1 		$32K Buy
+1,178
New +$37.4K ﹤0.01% 3244

Other funds holding LONA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cambridge Investment Research Advisors's LONA Position: Q2 2024 in Review

Cambridge Investment Research Advisors sold out of LeonaBio Inc (LONA) in Q2 2024, closing a stake of 1,178 shares — an estimated $32K sold.

Cambridge Investment Research Advisors first reported a position in LONA in Q1 2024 and held it in 1 quarter. The position peaked at $32K in Q1 2024. 65 funds tracked by Wall St. Rank hold LONA as of Q2 2024.

  • Cambridge Investment Research Advisors reported no remaining LeonaBio Inc position as of Q2 2024 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 1,178 LeonaBio Inc shares in Q2 2024, an estimated $32K.
  • Cambridge Investment Research Advisors first reported a position in LeonaBio Inc in Q1 2024 and held it in 1 quarter.
  • Cambridge Investment Research Advisors's LeonaBio Inc position peaked at $32K in Q1 2024.
  • 65 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2024.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2024, filed 26 Jul 2024.